Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening

Enrolling by invitation · Not applicable

Conditions studied: Diabetes Mellitus, Type 2, Pre Diabetes

In brief

The study team's central hypothesis is that the Parkland Diabetes Detection Program (PDDP) screening invitations targeted by race/ethnicity with culturally concordant messaging and tailored by glycemic risk (known PDM vs. unknown glycemic state) plus phone-based navigation of non-responders will be more effective at closing screening gaps than PDDP generic screening invitations and usual care, opportunistic screening alone.

Key facts

Study ID

NCT05730582

Run by

University of Texas Southwestern Medical Center

People needed

500000

Starts

2024-03-05

Expected to finish

2028-12-30

Last updated by the study team

2026-05-08

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is alive at time of data extraction
• Age >= 18 at time of data extraction and <76
• Visit with PCP at Parkland clinic in the last 18 months (548 days), where Encounter type = Virtual Visit or Encounter type = Office Visit
• Patient NOT included in Parkland Diabetes Registry
• Preferred language is Spanish or English
• Ethnicity is Hispanic or Non-Hispanic
• Race is White or Black
• Patient is not pregnant in last 12 months
• Exclusion Criteria for Study Population 1: Prediabetes Glycemic Risk Group
• Last A1C value <5.7 (normal)
• Last A1C value >6.4 (diabetes)
• Last A1C value = blank (unchecked)
• Last A1C date occurred within last 12 months from date of export
• Exclusion Criteria for Study Population 2: Score-Based Glycemic Risk Group
• Risk score <9
• Last A1C date occurred in last 30 months from date of export
• Last A1C value was >5.7 (PDM/DM)

Where it is running

• Parkland Health — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.